OVARY CANCER
Clinical trials for OVARY CANCER explained in plain language.
Never miss a new study
Get alerted when new OVARY CANCER trials appear
Sign up with your email to follow new studies for OVARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ovarian cancer drug combo trial halted early
Disease control TerminatedThis early-stage trial tested a new drug (STRO-002) combined with bevacizumab in 58 people with advanced ovarian, fallopian tube, or primary peritoneal cancer. The main goals were to check safety and find the best dose. The study was terminated, so results are limited.
Matched conditions: OVARY CANCER
Phase: PHASE1 • Sponsor: Sutro Biopharma, Inc. • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or combined with other cancer drugs (olaparib or enzalutamide), in people with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The study was…
Matched conditions: OVARY CANCER
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 04, 2026 16:31 UTC